Kevin Chen/Hyasynth
We make strains of yeast that produce cannabinoids. The cannabinoids are a collection of over 100 different compounds, of which the two most popular are THC and CBD.
CEO and Co-Founder, Hyasynth
Bio: We make strains of yeast that produce cannabinoids. The cannabinoids are a collection of over 100 different compounds, of which the two most popular are THC and CBD. They present an immense market opportunity that is at an intersection of nutritional, pharmaceutical and recreational use products.
The industry is developing and growing rapidly as legislation and consumer perspective shifts, and as more research points towards the health benefits of cannabinoids. To make these, and the other variations of cannabinoids, we've built our platform that is adaptable, efficient and scalable because it is based on engineered yeast. We grow yeast in fermenters, feeding just sugar and water, over the course of few days, after which we extract and purify the end product.
Website: https://www.hyasynthbio.com
Twitter: @hyasynthbio
Dr. Felix Moser/Synlife
I received my PhD in Chris Voigt's lab at MIT and went on to become the first employee of Synlife, a startup based in Cambridge, MA. Synlife is building synthetic minimal cells as an innovative platform for cell therapy.
CSO, Synlife Inc.
Email Address: fmoser76@gmail.com
Bio: I received my PhD in Chris Voigt's lab at MIT and went on to become the first employee of Synlife, a startup based in Cambridge, MA. Synlife is building synthetic minimal cells as an innovative platform for cell therapy. I live part time in Vancouver and aim to move there permanently. I am excited to actively contribute to the growing synthetic biology community in Canada.
Company Website: https://www.synlifebio.com/
Personal Website: http://felixmoserbio.com/
Ranomics
Ranomics enables transformative discoveries using genomics. Ranomics has a high throughput functional genomics pipeline that empowers drug discovery and synthetic biology.
Ranomics
Bio: Ranomics enables transformative discoveries using genomics. Ranomics has a high throughput functional genomics pipeline that empowers drug discovery and synthetic biology.
VariantFind™ is our flagship technology that drives our genomics pipeline. VariantFind™ by Ranomics enables transformative discoveries. Our Multisite Saturation Mutagenesis technology builds comprehensive variant libraries, helping our partners find meaningful variants in their research programs that will propel discovery and make better products. We are committed to providing top quality variant libraries at competitive costs with quick turn-around time.
Our VariantFind™ technology and functional genomics platform can also help pharmaceutical, biotech and genomic diagnostic companies identify actionable genetic variants. Unlike computational modeling, Ranomics’ platform systematically mutates and functionally characterizes each position on a gene in custom developed cell based assays.
Our studies can be applied towards understanding variant functionalities in the context of biological function, responsiveness or resistance behaviour to drugs/biologics and protein-protein binding interactions. By applying our functional genomics platform in mapping actionable variants, we provide partners with comprehensive knowledge to make better products and to provide better services.
Website: www.ranomics.com